Prosecution Insights
Last updated: October 04, 2026

Immundiagnostik AG

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Immundiagnostik AG operates a company patent portfolio within the Biotechnology and Pharmaceuticals technology area. The portfolio currently has 5 pending office actions, which are distributed among 5 distinct examiners. This distribution suggests that the company's intellectual property is being reviewed by a diverse group of individuals rather than being concentrated under a single person.

The prosecution activity spans 3 distinct art units, indicating that the portfolio covers several technical niches within the broader biotechnology sector. The busiest examiner for the portfolio is GERIDO, DWAN A, who is currently managing 1 pending office action. This indicates that even the most active examiner for this company only handles a small portion of the total 5 pending office actions.

For a practitioner, this distribution across 3 distinct art units and 5 distinct examiners requires a flexible prosecution strategy. Each of the pending office actions may encounter different examination styles. Coordination across the 3 distinct art units is necessary to ensure consistency in the company's patent claims and overall portfolio development.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
3
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (75%)
1
Medium (25%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (50%)
Double-patenting + other1 (25%)
Multi-statute (no §101)1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
25% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
25% of docket
2
Business / Other
50% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GERIDO, DWAN A 1 58.0% +30.4%
XU, XIAOYUN 1 60.0% +31.8%
WESTFALL, SARAH ANN 1 0.0% +0.0%
GORDON, MELENIE LEE 1 22.5% +45.3%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18685728 STOOL COLLECTION AND EXTRACTION SYSTEM FOR HUMAN MICROBIOM ANALYSIS WESTFALL, SARAH ANN 34d
18610782 METHOD OF MEASURING THE ENDOCYTIC VITAMIN D STATUS GERIDO, DWAN A —
17795487 TEST AND IN VITRO DIAGNOSIS OF IRRITABLE BOWEL SYNDROME GORDON, MELENIE LEE —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18610782 METHOD OF MEASURING THE ENDOCYTIC VITAMIN D STATUS GERIDO, DWAN A —
18685753 DIFFERENTIAL DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME XU, XIAOYUN —
17795487 TEST AND IN VITRO DIAGNOSIS OF IRRITABLE BOWEL SYNDROME GORDON, MELENIE LEE —

Top Art Units

Art UnitApps
3791 1
1651 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18610782 METHOD OF MEASURING THE ENDOCYTIC VITAMIN D STATUS GERIDO, DWAN A — §101§102§103§112 Non-Final OA — Pending Mar 20, 2024
18685753 DIFFERENTIAL DIAGNOSIS OF HISTAMINE INTOLERANCE SYNDROME XU, XIAOYUN — §103DP Non-Final OA — Pending Feb 22, 2024
18685728 STOOL COLLECTION AND EXTRACTION SYSTEM FOR HUMAN MICROBIOM ANALYSIS WESTFALL, SARAH ANN 3791 §103§112 Final Rejection 34d Pending Feb 22, 2024
17795487 TEST AND IN VITRO DIAGNOSIS OF IRRITABLE BOWEL SYNDROME GORDON, MELENIE LEE 1651 §101§103§112 Non-Final OA — Pending Jul 26, 2022

Managing Immundiagnostik AG's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month